Checkmate Pharmaceuticals (CMPI) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 43 254 sessions, May 27, 2021 to May 27, 2022
- Largest daily move
- +329.5% close of April 19, 2022
- 1-year change
- +57.2% closing prices, May 27, 2021 to May 27, 2022
- 1-month change
- +1.1% closing prices, April 27, 2022 to May 27, 2022
Company Description
Checkmate Pharmaceuticals (NASDAQ: CMPI) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $231.4M.
CMPI has gained 57.2% over the past year. The last closing price was $10.50.
This page collects what Stock Titan holds for CMPI, including price data and latest news.
Stock Performance
Checkmate Pharmaceuticals (CMPI) closed at $10.50 on May 27, 2022. Over the past 12 months, the price has gained 57.2%.
CMPI Metrics & Rankings
Price returns through May 27, 2022. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Checkmate Pharmaceuticals has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 1 with negative movement. Key topics include clinical trial, earnings, acquisition, conferences, management. View all CMPI news →
SEC Filings
CMPI Company Profile & Sector Positioning
Checkmate Pharmaceuticals (CMPI) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing CMPI often look at related companies in the same sector, including Voyager Therapeutics, Inc. (VYGR), Third Harmonic Bio, Inc. (THRD), AC Immune SA (ACIU), Humacyte, Inc. (HUMA), and ProQR Therapeutics N.V. (PRQR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CMPI's relative position within its industry.